Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 80, 2020 - Issue 4
Submit an article Journal homepage
432
Views
29
CrossRef citations to date
0
Altmetric
Original Articles

Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis

Luisa AgnelloDepartment of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, Palermo, Italy;
,
Tommaso PiccoliUnit of Neurology, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy; ORCID Iconhttps://orcid.org/0000-0003-3410-2067
ORCID Icon,
Matteo VidaliUnit of Clinical Chemistry, Maggiore della Carità Hospital, Novara, Italy;
,
Luca CuffaroUnit of Neurology, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy; ORCID Iconhttp://orcid.org/0000-0002-6853-1284
ORCID Icon,
Bruna Lo SassoDepartment of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, Palermo, Italy; ORCID Iconhttps://orcid.org/0000-0002-1047-5363
ORCID Icon,
Giorgia IacolinoDepartment of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, Palermo, Italy;
,
Vincenza Rosaria GiglioDepartment of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, Palermo, Italy;
,
Federica LupoUnit of Neurology, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy;
,
Pierpaolo AlongiUnit of Neurology, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo, Italy;
,
Giulia BivonaDepartment of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, Palermo, Italy; ORCID Iconhttps://orcid.org/0000-0003-1723-3305
ORCID Icon &
Marcello CiaccioDepartment of Biomedicine, Neurosciences and Advanced Diagnostics, Institute of Clinical Biochemistry, Clinical Molecular Medicine and Laboratory Medicine, University of Palermo, Palermo, Italy; ;Department of Laboratory Medicine, AOUP “P. Giaccone”, Palermo, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6120-9041
ORCID Icon show all
Pages 313-317 | Received 17 Dec 2019, Accepted 07 Mar 2020, Published online: 07 Apr 2020

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Sopan Nangare & Pravin Patil. (2022) Nanoarchitectured Bioconjugates and Bioreceptors Mediated Surface Plasmon Resonance Biosensor for In Vitro Diagnosis of Alzheimer’s Disease: Development and Future Prospects. Critical Reviews in Analytical Chemistry 52:5, pages 1139-1169.
Read now

Articles from other publishers (28)

Benoît Souchet, Alkéos Michaïl, Baptiste Billoir & Jérôme Braudeau. (2023) Biological Diagnosis of Alzheimer’s Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?. International Journal of Molecular Sciences 24:24, pages 17544.
Crossref
Abhinav Sharma, Lúcio Angnes, Naghmeh Sattarahmady, Masoud Negahdary & Hossein Heli. (2023) Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer’s Disease. Biosensors 13:7, pages 742.
Crossref
Amira Ben Hassine, Noureddine Raouafi & Felismina T.C. Moreira. (2023) Novel biomimetic Prussian blue nanocubes-based biosensor for Tau-441 protein detection. Journal of Pharmaceutical and Biomedical Analysis 226, pages 115251.
Crossref
Beatriz Nafría Jiménez, Adolfo Garrido Chércoles & Fermín Moreno Izco. (2023) Utilidad clínica de la proteína tau total y la ratio con su fracción fosforilada en el diagnóstico de enfermedad de Creutzfeldt-Jakob. Revista de Medicina de Laboratorio.
Crossref
Sonam Deshwal, Neha Dhiman & Rajat Sandhir. 2023. COVID-19 in Alzheimer's Disease and Dementia. COVID-19 in Alzheimer's Disease and Dementia 171 201 .
N. N. Koberskaya & F. A. Roshchin. (2022) Alzheimer's disease and COVID-19. Neurology, Neuropsychiatry, Psychosomatics 14:6, pages 89-97.
Crossref
Luis Daniel Goyzueta-Mamani, Miguel Angel Chávez-Fumagalli, Karla Alvarez-Fernandez, Jorge A. Aguilar-Pineda, Rita Nieto-Montesinos, Gonzalo Davila Del-Carpio, Karin J. Vera-Lopez & Christian L. Lino Cardenas. (2022) Alzheimer's Disease: A Silent Pandemic - A Systematic Review on the Situation and Patent Landscape of the Diagnosis. Recent Patents on Biotechnology 16:4, pages 355-378.
Crossref
In-Hwan Oh, Woo-Ri Shin, JinHee Ahn, Jin-Pyo Lee, Jiho Min, Ji-Young Ahn & Yang-Hoon Kim. (2022) The present and future of minimally invasive methods for Alzheimer's disease diagnosis. Toxicology and Environmental Health Sciences 14:4, pages 309-318.
Crossref
Barry D. Greenberg, Corinne Pettigrew, Anja Soldan, Jiangxia WangMei-Cheng Wang, Jacqueline A. Darrow, Marilyn S. Albert & Abhay Moghekar. (2022) CSF Alzheimer Disease Biomarkers. Neurology 99:15.
Crossref
Constance Delaby, Charlotte E. Teunissen, Kaj Blennow, Daniel Alcolea, Ivan Arisi, Elodie Bouaziz Amar, Anne Beaume, Aurélie Bedel, Giovanni Bellomo, Edith Bigot‐Corbel, Maria Bjerke, Marie‐Céline Blanc‐Quintin, Mercè Boada, Olivier Bousiges, Miles D Chapman, Mari L. DeMarco, Mara D'Onofrio, Julien Dumurgier, Diane Dufour‐Rainfray, Sebastiaan Engelborghs, Hermann Esselmann, Anne Fogli, Audrey Gabelle, Elisabetta Galloni, Clémentine Gondolf, Frédérique Grandhomme, Oriol Grau‐Rivera, Melanie Hart, Takeshi Ikeuchi, Andreas Jeromin, Kensaku Kasuga, Ashvini Keshavan, Michael Khalil, Peter Körtvelyessy, Agnieszka Kulczynska‐Przybik, Jean‐Louis Laplanche, Piotr Lewczuk, Qiao‐Xin Li, Alberto Lleó, Catherine Malaplate, Marta Marquié, Colin L. Masters, Barbara Mroczko, Léonor Nogueira, Adelina Orellana, Markus Otto, Jean‐Baptiste Oudart, Claire Paquet, Federico Paolini Paoletti, Lucilla Parnetti, Armand Perret‐Liaudet, Katell Peoc'h, Koen Poesen, Albert Puig‐Pijoan, Isabelle Quadrio, Muriel Quillard‐Muraine, Benoit Rucheton, Susanna Schraen, Jonathan M. Schott, Leslie M. Shaw, Marc Suárez‐Calvet, Magda Tsolaki, Hayrettin Tumani, Chinedu T Udeh‐Momoh, Lucie Vaudran, Marcel M Verbeek, Federico Verde, Lisa Vermunt, Jonathan Vogelgsang, Jens Wiltfang, Henrik Zetterberg & Sylvain Lehmann. (2021) Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimer's & Dementia 18:10, pages 1868-1879.
Crossref
Giulia Bivona, Matilda Iemmolo, Tommaso Piccoli, Luisa Agnello, Bruna Lo Sasso, Marcello Ciaccio & Giulio Ghersi. (2022) High Cerebrospinal Fluid CX3CL1 Levels in Alzheimer’s Disease Patients but Not in Non-Alzheimer’s Disease Dementia. Journal of Clinical Medicine 11:19, pages 5498.
Crossref
Tommaso Piccoli, Valeria Blandino, Laura Maniscalco, Domenica Matranga, Fabiola Graziano, Fabrizio Guajana, Luisa Agnello, Bruna Lo Sasso, Caterina Maria Gambino, Rosaria Vincenza Giglio, Vincenzo La Bella, Marcello Ciaccio & Tiziana Colletti. (2022) Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer’s Disease from Other Neurological Disorders. International Journal of Molecular Sciences 23:18, pages 10831.
Crossref
Luisa Agnello, Bruna Lo Sasso, Matteo Vidali, Concetta Scazzone, Caterina Maria Gambino, Tommaso Piccoli, Giulia Bivona, Anna Maria Ciaccio, Rosaria Vincenza Giglio, Vincenzo La Bella & Marcello Ciaccio. (2022) Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders. Journal of Clinical Medicine 11:11, pages 3139.
Crossref
Sakulrat Mankhong, Sujin Kim, Seongju Lee, Hyo-Bum Kwak, Dong-Ho Park, Kyung-Lim Joa & Ju-Hee Kang. (2022) Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers. Biomedicines 10:4, pages 850.
Crossref
Martin Fayolle, Sylvain Lehmann & Constance Delaby. (2022) Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt–Jakob disease in clinical practice. Journal of Neural Transmission 129:2, pages 133-139.
Crossref
Allison B. Reiss, Dalia Muhieddine, Ariel Z. De Leon, Iryna Voloshyna, Irving H. Gomolin & Aaron Pinkhasov. (2021) Tau and Alzheimer’s Disease: Molecular Mechanisms and Treatment Approaches. SN Comprehensive Clinical Medicine 4:1.
Crossref
Luisa Agnello, Bruna Lo Sasso, Matteo Vidali, Concetta Scazzone, Tommaso Piccoli, Caterina Maria Gambino, Giulia Bivona, Rosaria Vincenza Giglio, Anna Maria Ciaccio, Vincenzo La Bella & Marcello Ciaccio. (2021) Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease. Diagnostics 11:12, pages 2339.
Crossref
Sohee Moon, Sujin Kim, Sakulrat Mankhong, Seong Hye Choi, Manu Vandijck, Vesna Kostanjevecki, Jee Hyang Jeong, Soo Jin Yoon, Kyung Won Park, Eun-Joo Kim, Bora Yoon, Hee Jin Kim, Jae-Won Jang, Jin Yong Hong, Dong-Ho Park, Leslie M. Shaw & Ju-Hee Kang. (2021) Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans. Alzheimer's Research & Therapy 13:1.
Crossref
David Vogrinc, Katja Goričar, Tanja Kunej & Vita Dolžan. (2021) Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer’s Disease: Combining Literature Screening and Database Mining Approaches. Journal of Personalized Medicine 11:10, pages 946.
Crossref
Amira Ben Hassine, Noureddine Raouafi & Felismina T. C. Moreira. (2021) Novel Electrochemical Molecularly Imprinted Polymer-Based Biosensor for Tau Protein Detection. Chemosensors 9:9, pages 238.
Crossref
Luisa Agnello, Tiziana Colletti, Bruna Lo Sasso, Matteo Vidali, Rossella Spataro, Caterina Maria Gambino, Rosaria Vincenza Giglio, Tommaso Piccoli, Giulia Bivona, Vincenzo La Bella & Marcello Ciaccio. (2021) Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis. European Journal of Neurology 28:6, pages 1868-1875.
Crossref
Luisa Agnello, Caterina Maria Gambino, Bruna Lo Sasso, Giulia Bivona, Salvatore Milano, Anna Maria Ciaccio, Tommaso Piccoli, Vincenzo La Bella & Marcello Ciaccio. (2021) Neurogranin as a Novel Biomarker in Alzheimer’s Disease. Laboratory Medicine 52:2, pages 188-196.
Crossref
Giulia Bivona, Bruna Lo Sasso, Caterina Maria Gambino, Rosaria Vincenza Giglio, Concetta Scazzone, Luisa Agnello & Marcello Ciaccio. (2021) The Role of Vitamin D as a Biomarker in Alzheimer’s Disease. Brain Sciences 11:3, pages 334.
Crossref
Marcello Ciaccio, Bruna Lo Sasso, Concetta Scazzone, Caterina Maria Gambino, Anna Maria Ciaccio, Giulia Bivona, Tommaso Piccoli, Rosaria Vincenza Giglio & Luisa Agnello. (2021) COVID-19 and Alzheimer’s Disease. Brain Sciences 11:3, pages 305.
Crossref
Ngoc Van Thanh NguyenMyriam Taverna, Claire SmadjaThanh Duc Mai. (2020) Recent Electrokinetic and Microfluidic Strategies for Detection of Amyloid Beta Peptide Biomarkers: Towards Molecular Diagnosis of Alzheimer's Disease. The Chemical Record 21:1, pages 149-161.
Crossref
Timo Tuovinen, Janne Kananen, Zalan Rajna, Johannes Lieslehto, Vesa Korhonen, Riikka Rytty, Heli Mattila, Niko Huotari, Lauri Raitamaa, Heta Helakari, Ahmed Abou Elseoud, Johanna Krüger, Pierre LeVan, Osmo Tervonen, Juergen Hennig, Anne M. Remes, Maiken Nedergaard & Vesa Kiviniemi. (2020) The variability of functional MRI brain signal increases in Alzheimer's disease at cardiorespiratory frequencies. Scientific Reports 10:1.
Crossref
Toshihiro Watanabe, Yuki Fujimoto, Aya Morimoto, Mai Nishiyama, Akinori Kawai, Seiki Okada, Motohiro Aiba, Tomoharu Kawano, Mina Kawahigashi, Masashi Ishizu, Hiroyasu Mori, Munehide Matsuhisa, Akiko Hata, Makoto Funaki & Seiichi Hashida. (2020) Development of fully automated and ultrasensitive assays for urinary adiponectin and their application as novel biomarkers for diabetic kidney disease. Scientific Reports 10:1.
Crossref
Ashvini Keshavan, Henrietta Wellington, Zhongbo Chen, Ayesha Khatun, Miles Chapman, Melanie Hart, David M. Cash, William Coath, Thomas D. Parker, Sarah M. Buchanan, Sarah E. Keuss, Matthew J. Harris, Heidi Murray‐Smith, Amanda Heslegrave, Nick C. Fox, Henrik Zetterberg & Jonathan M. Schott. (2020) Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.